Publications

Metabolic changes of human induced pluripotent stem cell-derived cardiomyocytes and teratomas after transplantation 

Yusuke Soma, Shugo Tohyama*, Akiko Kubo, Tomoteru Yamasaki, Noriko Kabasawa, Kotaro Haga, Hidenori Tani, Yuika Morita-Umei, Tomohiko C. Umei, Otoya Sekine, Masashi Nakamura, Taijun Moriwaki, Sho Tanosaki, Shota Someya, Yujiro Kawai, Masatoshi Ohno, Yoshikazu Kishino, Hideaki Kanazawa, Jun Fujita, Ming-Rong Zhang, Makoto Suematsu, Keiichi Fukuda, Masaki Ieda

iScience 27(11) 111234-111234, November 2024

Maturation of Human iPSC-Derived Cardiac Microfiber with Electrical Stimulation Device 

Akari Masuda, Yuta Kurashina, Hidenori Tani, Yusuke Soma, Jumpei Muramatsu, Shun Itai, Shugo Tohyama*, Hiroaki Onoe*

Advanced healthcare materials 13(27) e2303477, 29 May 2024

Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids. 

Hideki Kobayashi, Shugo Tohyama*, Hajime Ichimura, Noburo Ohashi, Shuji Chino, Yusuke Soma, Hidenori Tani, Yuki Tanaka, Xiao Yang, Naoko Shiba, Shin Kadota, Kotaro Haga, Taijun Moriwaki, Yuika Morita-Umei, Tomohiko C Umei, Otoya Sekine, Yoshikazu Kishino, Hideaki Kanazawa, Hiroyuki Kawagishi, Mitsuhiko Yamada, Kazumasa Narita, Takafumi Naito, Tatsuichiro Seto, Koichiro Kuwahara, Yuji Shiba*, Keiichi Fukuda

Circulation 150(8) 611-621, 26 April 2024

PRESS RELEASE

H1FOO-DD promotes efficiency and uniformity in reprogramming to naive pluripotency. 

Akira Kunitomi, Ryoko Hirohata, Mitsujiro Osawa, Kaho Washizu, Vanessa Arreola, Norikazu Saiki, Tomoaki M Kato, Masaki Nomura, Haruko Kunitomi, Tokiko Ohkame, Yusuke Ohkame, Jitsutaro Kawaguchi, Hiroto Hara, Kohji Kusano, Takuya Yamamoto, Yasuhiro Takashima, Shugo Tohyama, Shinsuke Yuasa, Keiichi Fukuda, Naoko Takasu, Shinya Yamanaka

Stem cell reports 19(5) 710-728, 23 April 2024

Pluripotent stem cell-based cardiac regenerative therapy for heart failure. 

Yusuke Soma, Hidenori Tani, Yuika Morita-Umei, Yoshikazu Kishino, Keiichi Fukuda, Shugo Tohyama*

Journal of molecular and cellular cardiology 187 90-100, February 2024

患者まで届いている再生医療 難治性重症心不全患者を対象とした同種iPS細胞由来心筋スフェロイド移植

岸野 喜一, 市原 有起, 遠山 周吾

再生医療 23(2) 78-83, May 2024

三次元新組織の開発とその応用

谷 英典, 遠山 周吾*

実験医学 42(5) 728-735, March 2024

成熟度の高いオルガノイドを試験管内でいかに作り上げるか? ブタ臓器特異的細胞外基質の特性と心臓由来コラーゲンの利用

谷 英典, 遠山 周吾, 小林 英司

Organ Biology 31(1) 012-016, 2024

【心不全の最新治療-再生医療を用いた最新の知見】培養液を利用したヒトiPS細胞由来心筋細胞の大量選別法と品質評価法の開発

梅井 智彦, 森田 唯加, 遠山 周吾

カレントテラピー 42(1) 20-25, January 2024